Forthcoming

Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19

Erciyes MIS-C Guideline


Abstract views: 104

Authors

DOI:

https://doi.org/10.51271/jpea-2022-182

Keywords:

COVID-19, MIS-C, guideline, Pediatric

Abstract

Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is unclear; however, it is thought to develop 4 to 6 weeks after infection. This guideline aims to provide a framework for physicians to use to guide the evaluation of patients and management of those diagnosed with MIS-C.

Downloads

Published

2022-06-20

How to Cite

Cetin, B. S., Kısaarslan, A. P., Baykan, A., Akyıldız, B. N., & Poyrazoglu, H. (2022). Erciyes Clinical Guideline For Multisystem Inflammatory Syndrome In Children (MIS-C) Associated With COVID-19: Erciyes MIS-C Guideline. The Journal of Pediatric Academy. https://doi.org/10.51271/jpea-2022-182

Issue

Section

Clinical Guidance